Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003

Ejemplares similares

• Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
  por: Vora, A, et al.
  Publicado: (2008)
• Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
  por: Qureshi, A, et al.
  Publicado: (2010)
• Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
  por: Chessels, J, et al.
  Publicado: (1997)
• Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
  por: Hann, I, et al.
  Publicado: (2000)
• Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
  por: Chessells, J, et al.
  Publicado: (1997)